Biohacker Protocol (experimental) Dose: 0.25 mg (= 10 clicks) Duration: Continuous Frequency: Twice daily Cycle Interval: No fixed interval / take 1 week off every 8 weeks Goal / Description: Micro-dosing approach focusing on steady fat metabolism
BPC-157 has not been entered into any FDA trials in this county or similar trials in any other country, and it is not FDA approved for any medical use
stable at room temperature for approximately 3 weeks Reconstituted BPC-157: Store at 2 to 8C (refrigerator temperature) and use within 4 weeks Protect from light and avoid repeated freeze-thaw cycles Never use the solution if it appears cloudy or contains particles Side Effects Preclinical animal studies have demonstrated a favorable safety profile for BPC-157, with no acute toxicity observed across multiple organ systems, including liver, spleen, lung, kidney, brain, thymus, prostate, and ovaries at doses ranging from 6 g/kg to 20 mg/kg over 6-week periods
BPC-157/TB-500 BLEND 10MG (BPC-157 5mg/TB-500 5mg) A dual-peptide research formulation utilized in preclinical research involving cellular signaling, connective tissue organization, cytoskeletal regulation, and extracellular matrix dynamics
Studies comparing scar tissue in TB500-treated versus untreated injuries show better collagen organization, less fibrosis, and improved elasticity in treated samples